摘要:
This invention provides a method for reducing hypertropic scarring resulting from dermal wound healing in a subject in need which comprises administering to the subject an antisense oligonucleotide which inhibits expression of connective tissue growth factor (CTGF) in an amount effective to inhibit expression of CTGF and thereby reduce hypertrophic scarring.
摘要:
A wound healing composition is a pharmaceutical dosage unit form including a wound-healing amount of an aporphinoid alkaloid such as taspine free acid, dissolved in a physiologically tolerable non-aqueous solvent such as dimethylsulfoxide.
摘要:
Provided herein are compositions and methods for preventing or reducing scar formation (e.g., hypertrophic scars). For example, provided herein are methods of administrating HMG-CoA-inhibiting agents for preventing or reducing scar formation.